X-linked hypophosphatemia (XLH) requires a clinical and biochemical assessment alongside genetic testing. The central finding is inappropriate renal phosphate loss in someone with low blood phosphate. A compatible PHEX result can establish the molecular diagnosis, but a variant of uncertain significance cannot settle it. The practical question is whether the phenotype, phosphate handling and genetic evidence agree. GeneReviews
Recognize a disorder that changes across life
Phosphate is essential for bone and tooth mineralization. In XLH, inadequate phosphate availability can produce rickets in growing children and osteomalacia in adults. Childhood clues include reduced growth and progressive leg bowing. Adults may present with painful stress fractures, restricted movement, osteoarthritis or enthesopathy—mineral deposits around tendon and ligament attachments. Dental abscesses can provide another clue. MedlinePlus Genetics: XLH
Features vary substantially, including within a family. Some people have low phosphate with few other findings. Consequently, a mildly affected parent does not establish that a child will have mild disease. Document childhood growth, limb alignment, dental history and adult skeletal symptoms rather than using one relative’s experience as a prognosis. Clinical variability
Interpret low phosphate before naming its cause
A blood phosphate result describes a concentration, not its explanation. Phosphate supports energy production and muscle and nerve function as well as the skeleton. The kidneys normally conserve it when blood levels fall; intestinal absorption also helps determine availability. Calcium, vitamin D and parathyroid hormone influence this balance. MedlinePlus: phosphate testing
Children generally have higher phosphate concentrations than adults, making age-appropriate interpretation essential. Low results can accompany vitamin D deficiency, hyperparathyroidism, malnutrition, malabsorption or medication exposure. Review these possibilities before attributing a low value to inherited disease. Record medicines and supplements because they can also affect test interpretation. Interpreting phosphate results
Ask whether the kidneys are conserving phosphate
Paired blood and urine measurements allow assessment of renal phosphate handling. TmP/GFR—the tubular maximum phosphate reabsorption relative to glomerular filtration rate—helps identify inappropriate renal loss. Interpret it against age-related ranges. FGF23 measurements also require care: assay differences and sample handling limit interpretation, and a laboratory result should remain connected to the biochemical picture. Biochemical assessment
Explain PHEX biology without overstating the mechanism
PHEX encodes an enzyme involved in bone and tooth biology. Disease-causing variants lead to increased fibroblast growth factor 23, or FGF23, a protein involved in phosphate regulation. Increased FGF23 activity reduces renal phosphate reabsorption and intestinal phosphate availability, contributing to impaired skeletal mineralization. MedlinePlus Genetics: PHEX
The molecular connection between altered PHEX function and increased FGF23 is incompletely understood. PHEX may also interact with molecules that regulate mineral deposition in bones and teeth. These proposed interactions remain areas of research. A useful explanation distinguishes the established clinical association from an unfinished account of every molecular step. PHEX function and remaining questions
Make the genetic report answer a defined question
A pathogenic or likely pathogenic PHEX variant supports diagnosis in the appropriate clinical setting. A negative sequencing result requires review of assay coverage, including deletion and duplication analysis. An uncertain variant neither confirms nor excludes XLH. These distinctions prevent an ambiguous report from replacing the clinical assessment. Diagnostic testing and interpretation
XLH affects females as well as males. Under the usual X-linked inheritance pattern, an affected father transmits the variant to every daughter and no sons; an affected mother has a 50% transmission probability in each pregnancy. These probabilities describe inheritance, while severity remains variable. XLH inheritance
Keep care goals separate from research questions
Established specialist care includes phosphate with active vitamin D or FGF23-targeted treatment with burosumab, with monitoring appropriate to the treatment. Management also addresses skeletal and dental disease. Research into PHEX biology does not itself establish a new clinical intervention. Management overview
A useful referral summary therefore records three distinct conclusions: whether phosphate is low for age, whether renal loss is inappropriate, and whether the genetic result explains the phenotype. Keeping those answers explicit makes unresolved evidence visible and gives the specialist team a focused diagnostic question.